Related Experiment Video
Updated: Aug 13, 2026

11:00
Microfluidic Chip for Axonal Injury Models Construction and Enabling Multi-Omics Analysis
Published on: October 14, 2025
Nerve Injury-on-a-Chip Uncovers Extracellular Matrix and Mitochondrial Roles in Axonal Regeneration
Donghee Lee1, Imran I G Rather1, Andrew T Dudley2
1Department of Surgery-Transplant and Mary & Dick Holland Regenerative Medicine Program, University of Nebraska Medical Center, Omaha, NE 68198, USA.
Acta Biomaterialia
|August 11, 2026
Summary
A novel nerve injury-on-a-chip (NI-Chip) platform enables quantitative analysis of peripheral nerve regeneration. This system demonstrates that extracellular matrix cues and mitochondrial transport modulation significantly impact axonal regrowth, paving the way for new therapies.
Area of Science:
- Biomaterials Science
- Neuroscience
- Regenerative Medicine
Background:
- Peripheral nerve regeneration is hindered by limited functional recovery and a lack of physiologically relevant in vitro models.
- Evaluating biomaterials and mitochondria-targeted therapies for nerve repair requires dynamic, quantitative analysis systems.
Purpose of the Study:
- To develop and validate a nerve injury-on-a-chip (NI-Chip) platform for real-time, quantitative assessment of axonal regeneration dynamics.
- To investigate the influence of extracellular matrix composition and mitochondrial transport on nerve regeneration.
- To explore the potential of sustained drug delivery via nanofibers for enhancing peripheral nerve repair.
Main Methods:
- Integration of dorsal root ganglion explants, aligned nanofibers, and microfluidics in a controlled axotomy model.
- Real-time, quantitative analysis of axonal regeneration velocity and mitochondrial dynamics.
- Pharmacological modulation of mitochondrial transport using compound M1 and assessment of sustained delivery via M1-loaded nanofibers.
Main Results:
- Extracellular matrix composition significantly affects axonal regeneration velocity; laminin promoted faster growth than fibronectin.
- Mitochondrial transport enhancement using compound M1 dose-dependently improved axonal regeneration by increasing mitochondrial motility, particularly retrograde transport.
- M1 treatment efficacy was maintained in older neurons, indicating mitochondrial dynamics as an age-independent therapeutic target.
- Localized and sustained delivery of M1 via nanofibers further enhanced axonal regrowth.
Conclusions:
- The NI-Chip provides a versatile platform for dissecting the interplay between biomaterials, mitochondrial dynamics, and axonal regeneration.
- Mitochondrial dynamics represent a promising, age-independent target for enhancing peripheral nerve repair.
- This platform facilitates the design and optimization of biomaterials and therapeutic strategies for clinical translation in peripheral nerve repair.
